Pharmaceutical Dissolution Testing Services Market Size Worth $1,308.65 Million By 2030 | CAGR: 8.2%

Pharmaceutical Dissolution Testing Services Market Size Worth $1,308.65 Million By 2030 | CAGR: 8.2%

The global pharmaceutical dissolution testing services market size is expected to reach USD 1,308.65 million by 2030, according to a new study by Polaris Market Research. The report “Pharmaceutical Dissolution Testing Services Market Share, Size, Trends, Industry Analysis Report, By Method (In Vitro, and In Vivo); By Dosage Form; By Dissolution Apparatus; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.


Pharmaceutical dissolution testing service's significance is expanding because, to be effective, medicine must be extracted from the product and absorbed in the digestive system before it can be ingested into the blood vessels. The ease with which a medication dissolves from the dosage form, in other words, determines how quickly and the amount of the medicine is ingested. As per the FDA Dissolution data, In July 2022, there were 1444 drug items in the oral solid dosage form. The administration of the solid oral dosage is very straightforward, and it is easy to distinguish one oral solid dose product from another.


Additionally, manufacturing techniques for solid oral doses are advanced. To confirm that the drug product is safe and effective, each has a repeatable distribution of components and uniformity in dissolving and bioavailability. The level of consumer demand significantly impacts how well-performing essential businesses perform. Consumers today are more concerned with self-care, which leads to the higher purchase of healthcare items as a result of intensified commercial efforts, rising awareness levels, improving access, and government initiatives. Over the predicted period, it is anticipated that consumption levels will increase dramatically.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:


Furtherly, the partnership among the major players for dissolution testing services is driving market growth. For instance, in April 2018, In the area of dissolution testing, METTLER TOLEDO announced a new collaboration with SOTAX.  Also, in November 2019, SOTAX and Triskelion agreed that SOTAX would represent Triskelion's unrivaled TIM gastrointestinal simulation technology in the Americas and handle sales and customer support. Therefore, these factors, such as collaboration among major players, bolstered the growth of pharmaceutical dissolution testing services.


Pharmaceutical Dissolution Testing Services Market Report Highlights

  • The paddle segment accounted for a major revenue share. An engine with a controlled and changeable speed is fixed vertically to the paddle. For dissolving, the tablet or capsule is placed into a flask with a circular bottom, and the apparatus is maintained at a constant temperature.
  • Asia-Pacific is expected to grow at a high CAGR over the projected period due to the rising drug approval, investment in drug development, and the rising chronic disease in the region. Also, an increase in pharmaceutical research initiatives is projected to propel the industry's growth.
  • The global players include Avivia BV, Almac Group, Agilent Technologies, Catalent, Eurofins Scientific Incorporation, Intertek Group, Kinesis Ltd., Pace Analytical Life, SGS SA, Sotax AG, Thermofisher Scientific, Teledyne Hanson Research, and West Pharmaceutical Services.


Polaris Market Research has segmented the pharmaceutical dissolution testing services market report based on method, dosage form, dissolution apparatus, and region:


Pharmaceutical Dissolution Testing Services, Method Outlook (Revenue - USD Million, 2018 - 2030)

  • In Vitro
  • In Vivo

Pharmaceutical Dissolution Testing Services, Dosage Form Outlook (Revenue - USD Million, 2018 - 2030)

  • Capsules
  • Tablets
  • Others

Pharmaceutical Dissolution Testing Services, Dissolution Apparatus Outlook (Revenue - USD Million, 2018 - 2030)

  • Basket
  • Paddle
  • Others

Pharmaceutical Dissolution Testing Services, Regional Outlook (Revenue - USD Million, 2018 - 2030)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa